Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cameco

Energy Transfer LP Unit

One simple signal that investors can use to decide if a stock is likely to move higher is to look at analyst sentiment. An analyst is a market professional employed by either funds that buy securities (I.e.

3 Stocks that Analysts Continue to Upgrade into Earnings Season

Automatic Data Processing

Chevron

Pfizer

QUALCOMM

This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields just under 3%, we present two other groups of five DGI stocks each, with the goal of moderate to high yields.

5 Relatively Safe And Cheap Dividend Stocks To Invest In - July 2023

Apple

Amazon

Alphabet

Microsoft

NVIDIA

Tesla

Exxon Mobil

An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities.

The Top Stocks Sold by Institutional Investors

PayPal

Alphabet is the cheapest FAANG stock despite its huge gains this year. PayPal's valuation is the most attractive it's ever been.

61% of Top Investors Think We're in a New Bull Market: 3 Stocks to Buy If They're Right

Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.

UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?

Enbridge

Medtronic

UnitedHealth Group might seem like a boring insurance stock, but it has achieved thrilling dividend growth rates in recent years. Steadily reliance on healthcare makes Medtronic's medical device business one that income investors want in their portfolios.

3 Dividend Growth Stocks to Buy in July and Never Sell

Salesforce

Walgreens

Walgreens slashed its guidance as its pivot to healthcare continues to underwhelm. Salesforce is seeing growth slow even as it sees a new opportunity in AI.

Is It Time to Buy the Dow Jones' 3 Worst-Performing June Stocks?

FedEx

Although these companies are from different sectors, we compare them because they have a similar P/EBIT ratio of 14x-15x.

Which Stock Is A Better Pick For The Next Three Years – FedEx Or UNH?

Bank of America

Walmart

Bank of America looks like the best bank stock set to profit from AI. UnitedHealth Group should benefit from AI throughout all of its businesses.

Prediction: These 3 Stocks Will Be Among the Biggest Non-Tech AI Winners

Broadcom

A company displaying free cash flow strength has freedom for growth opportunities, can consistently shell out dividends, and wipe out debt easily.

These 3 Companies Are Cash-Generating Machines

UnitedHealth Group UNH announced its acquisition of Amedisys Inc. AMED for a whopping $3.3 billion or $101 per share in a significant move to strengthen its position in the home healthcare sector. This all-cash deal will allow UnitedHealth to expand its home healthcare business, providing enhanced care services to a wider range of patients.

UnitedHealth Group (UNH) Expands Home Healthcare Business

Amedisys

In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, as had been reported here, Amedisys, the home health and hospice firm, agreed to be acquired by UnitedHealth's Optum.

UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems

UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys.

UnitedHealth Buys Amedisys for $3.3 Billion

UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.

UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable

The unsolicited offer from UnitedHealth outbid a $2.8 billion deal.

Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger

Home health company Amedisys has agreed to a $3.3 billion merger with UnitedHealth Group. The deal calls for the acquisition of Amedisys' outstanding common stock in an all-cash transaction for $101 per share and places Amedisys under the umbrella of UnitedHealth's Optum arm, according to a Monday (June 26) press release.

Amedisys Agrees to $3.3 Billion UnitedHealth Merger

The move for the healthcare-service provider is worth $101 a share.

UnitedHealth Agrees All-Cash Deal to Buy Amedisys

Amedisys Inc on Monday agreed to acquired by UnitedHealth Group for $101 per share in cash, and terminated an all-stock deal to be bought by Option Care Health Inc.

Amedisys agrees to UnitedHealth buyout offer, scraps Option Care deal

Option Care Health

Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early-May. Under terms of deal with UnitedHealth, each Amedisys share will be converted into the right to receive $101 in cash, which represents as 10.7% premium to Friday's closing price of $91.21.

Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health

Costco

Coterra Energy

Deere & Company

Intuit

Lennar

Microchip Technology

M&T Bank

Visa

Our Top 10 Picks For Dividend Growth Stocks - June 2023

Boehringer Ingelheim's biosimilar of AbbVie Inc's blockbuster arthritis drug Humira will be included in the reimbursement list of UnitedHealth Group Inc's OptumRx unit, the German drugmaker said on Friday.

UnitedHealth unit to add Boehringer's Humira biosimilar to reimbursement list

Health care stocks to check out in the stock market today.

Top Health Care Stocks To Buy Today? 2 To Know

UnitedHealth Group's stock has been in negative territory this year and underperforming the S&P 500. Rising surgeries mean the insurer is going to be spending more on medical claims, pushing down its earnings.

Is UnitedHealth Group Stock in Trouble?

PHOENIX--(BUSINESS WIRE)--UnitedHealthcare Community Plan of Arizona has been awarded the industry-recognized Health Plan Accreditation and Long-Term Services and Supports (LTSS) Distinction by the National Committee for Quality Assurance (NCQA). NCQA accredits and certifies a wide range of health care organizations and manages the evolution of HEDIS®, the most widely used performance measurement tool in health care. UnitedHealthcare Community Plan of Arizona earned NCQA Health Plan Accreditati.

UnitedHealthcare Community Plan of Arizona Awarded NCQA's Health Plan Accreditation and Long-Term Services & Supports Distinction

Shell PLC

UnitedHealth is a top dividend growth stock that has been generously increasing its payouts for years. Shell has performed exceptionally well, and with oil prices looking more stable, that should continue.

News for UnitedHealth Group Stock (UNH)